Related Experiment Video
Updated: Oct 21, 2025

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
[Congenital thrombocytopenia]
1Department of Pediatrics, Tohoku University Graduate School of Medicine.
Congenital thrombocytopenia is a group of heterogeneous disorders caused by mutations in the responsible genes that play crucial roles in normal megakaryopoiesis and subsequent platelet production. The diagnosis of congenital thrombocytopenia is clinically necessary to distinguish it from immune thrombocytopenia and select the appropriate therapeutic modalities. The number of responsible genes reported so far is up to 56, and data on their targeted sequencing and subsequent exome sequencing analysis are available in Japan. Here, we report the disease outlines, disease classification based on platelet sizes (small, normal, large, and giant platelets), disease descriptions, consultation system, list of responsible genes, therapeutic options, and follow-up system for congenital thrombocytopenia.
Congenital thrombocytopenia is a group of heterogeneous disorders caused by mutations in the responsible genes that play crucial roles in normal megakaryopoiesis and subsequent platelet production. The diagnosis of congenital thrombocytopenia is clinically necessary to distinguish it from immune thrombocytopenia and select the appropriate therapeutic modalities. The number of responsible genes reported so far is up to 56, and data on their targeted sequencing and subsequent exome sequencing analysis are available in Japan. Here, we report the disease outlines, disease classification based on platelet sizes (small, normal, large, and giant platelets), disease descriptions, consultation system, list of responsible genes, therapeutic options, and follow-up system for congenital thrombocytopenia.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

